CALC - Company ID 0001534133
The table below shows CalciMedica, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$4.86M | -$4.88M | -$4.71M | -$5.36M | -$3.63M | -$9.26M |
| Capital expenditure | $0.00 | $9.00K | $0.00 | - | $4.00K | $136.00K |
| Investing cash flow | $1.50M | -$1.24M | -$13.10M | $4.75M | -$4.00K | -$13.66M |
| Dividends paid | - | - | - |
CalciMedica, Inc. reported operating cash flow of -$21.18M for fiscal year 2025. That is down 0.2% from -$21.15M in fiscal 2024. Over the 7 fiscal years shown, operating cash flow grew from -$31.21M (FY 2019) to -$21.18M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| - |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | $0.00 | $10.74M | $19.04M | $23.52M | $1.00K | $92.00K |